Biotoxtech Co. Ltd Capital Reinvestment Ratio

Latest as of March 2026: 2.69x

Biotoxtech Co. Ltd capital reinvestment ratio. Biotoxtech Co. Ltd (086040) has a Capital Reinvestment Ratio of 2.69x as of March 2026, meaning it reinvests 3% of its operating cash flow (₩604.17 Million) in capital expenditures (₩1.62 Billion). Check Biotoxtech Co. Ltd (086040) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

2.69x
Capex / Operating Cash Flow

Operating Cash Flow

₩604.17 Million
KRW

Capital Expenditures

₩1.62 Billion
KRW

Data as of

Mar 2026
Most recent filing

Capital Reinvestment Ratio of Biotoxtech Co. Ltd (2011–2025)

Capital reinvestment ratio of Biotoxtech Co. Ltd from 2011 to 2025. This chart tracks Biotoxtech Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore 086040 net assets growth trend to track the company's year-over-year net asset growth rate.

Biotoxtech Co. Ltd Capital Reinvestment Ratio by Year (2011–2025)

Biotoxtech Co. Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see Biotoxtech Co. Ltd (086040) cash flow conversion.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.34x ₩6.64 Billion ₩2.23 Billion ▼ -80.8%
2021 1.75x ₩4.35 Billion ₩7.62 Billion ▲ +485.5%
2020 0.30x ₩4.56 Billion ₩1.37 Billion ▼ -3.8%
2019 0.31x ₩1.44 Billion ₩449.34 Million ▼ -58.9%
2018 0.76x ₩3.06 Billion ₩2.32 Billion ▲ +33.8%
2017 0.57x ₩6.02 Billion ₩3.41 Billion ▲ +508.3%
2016 0.09x ₩5.28 Billion ₩491.52 Million ▼ -91.8%
2012 1.13x ₩1.63 Billion ₩1.85 Billion ▲ +25.5%
2011 0.90x ₩3.28 Billion ₩2.96 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow